SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $130,000 | -4.4% | 22,487 | 0.0% | 0.04% | 0.0% |
| Q1 2016 | $136,000 | -33.7% | 22,487 | 0.0% | 0.04% | +13.5% |
| Q4 2015 | $205,000 | +61.4% | 22,487 | 0.0% | 0.04% | +85.0% |
| Q3 2015 | $127,000 | -49.0% | 22,487 | 0.0% | 0.02% | -52.4% |
| Q2 2015 | $249,000 | -29.5% | 22,487 | 0.0% | 0.04% | -44.0% |
| Q1 2015 | $353,000 | +3.2% | 22,487 | 0.0% | 0.08% | -1.3% |
| Q4 2014 | $342,000 | +40.7% | 22,487 | 0.0% | 0.08% | -5.0% |
| Q3 2014 | $243,000 | -29.2% | 22,487 | 0.0% | 0.08% | -30.4% |
| Q2 2014 | $343,000 | -15.7% | 22,487 | 0.0% | 0.12% | -33.1% |
| Q1 2014 | $407,000 | +30.4% | 22,487 | 0.0% | 0.17% | +70.3% |
| Q4 2013 | $312,000 | – | 22,487 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |